A patient with PMP22-related hereditary neuropathy and DBH-gene-related dysautonomia
Anna Bartoletti-Stella1, Giacomo Chiaro1, Giovanna Calandra-Buonaura1,2
1Department of Biomedical and Neuromotor Sciences, Alma Mater Studiorum University of Bologna, Via Ugo Foscolo 7, 40123, Bologna, Italy.
Abstract:
Recurrent focal neuropathy with liability to pressure palsies is a relatively frequent autosomal-dominant demyelinating neuropathy linked to peripheral myelin protein 22 (PMP22) gene deletions. The combination of PMP22 gene mutations with other genetic variants is known to cause a more severe phenotype than expected. We present the case of a patient with severe orthostatic hypotension since 12 years of age, who inherited a PMP22 gene deletion from his father. Genetic double trouble was suspected because of selective sympathetic autonomic disturbances. Through exome-sequencing analysis, we identified two novel mutations in the dopamine beta hydroxylase gene. Moreover, with interactome analysis, we excluded a further influence on the origin of the disease by variants in other genes. This case increases the number of unique patients presenting with dopamine-β-hydroxylase deficiency and of cases with genetically proven double trouble. Finding the right, complete diagnosis is crucial to obtain adequate medical care and appropriate genetic counseling.
More Related Videos
Related Concept Videos
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Parkinson's Disease: Overview
Neural Regulation
Pedigree Analysis
Abnormal Proliferation


